Collaboration is the cornerstone of innovation and impact. At Biocon Biologics, we’re driving a transformation in global healthcare — from scientific discovery to large-scale commercialization — to make high-quality biosimilars accessible and affordable worldwide.   As our

Here is Step 2 of our #5StepsInTime for Breast Cancer Awareness Month.    Regular self-examinations are a simple yet powerful way to stay in tune with your body.    By spending a few minutes each month checking for changes, you can notice things early - giving yourself the

Breast Cancer is the most frequently diagnosed cancer in women worldwide.   Nearly half of its cases occur in women with no other risk factors besides age and gender. Spreading awareness, recognizing early warning signs, and prioritizing early detection are key steps in

On October 23rd, Matt Erick, Chief Commercial Officer, Advanced Markets at Biocon Biologics, spoke at The Atlantic’s “The Next Frontier for Accessible Medicines” event. Matt joined Alex Keeton, Executive Director of the Biosimilars Council and Senior Vice President of Policy at

Innovating at Scale: Biocon Biologics will be at CPHIFrankfurt 2025! We’re redefining possibilities in biosimilars — taking cutting-edge science driven by purpose from the lab to global impact. Meet our experts at @CPHI_Events  Frankfurt and explore collaboration opportunities

Biocon Biologics in Eastern Europe! At Biocon Biologics, our mission is to expand access to life-changing treatments for patients everywhere. In Albania, Bosnia, Bulgaria, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Serbia, and Slovenia, we are committed to

Biocon Biologics is pleased to be present at the Taipei Breast Cancer Symposium on October 25–26. The event brings together global experts, clinicians, and researchers to share the latest insights in breast cancer management. We look forward to engaging with the oncology

We’re pleased to announce the expansion of our strategic partnership with Civica, Inc., to increase access to affordable medicines for U.S. patients with diabetes.  The multi-year transformational agreement between Biocon Biologics and @CivicaRx creates an exclusive

Our teams in Germany, Austria, Croatia, Czech Republic, Slovakia, and Switzerland, are dedicated to making healthcare systems more sustainable through biosimilars. Across all the countries where we operate, we collaborate closely with various healthcare stakeholders to improve

Advancing IBD care through global scientific exchange We were proud to participate in the United European Gastroenterology Week (UEGW) in Berlin, joining over 12,200 participants from 115 countries. This prestigious gathering reinforced our unwavering commitment to supporting

Biocon Biologics at ASCOMOS 2025: Advancing Oncology Together Biocon Biologics was proud to participate in the 36th Annual Scientific Congress of the Malaysian Oncological Society (ASCOMOS 2025), held from September 26–28. The congress brought together leading oncologists,

Primary care innovation in Granada Biocon Biologics was proud to participate in the 47th National Congress of SEMERGEN in Granada, reinforcing our dedication to expanding access to biosimilars within primary care settings across Spain. As Spain's largest event for family

Looking forward to CPHI Frankfurt 2025! We're excited to participate in CPHI Europe, taking place from 28-30 October at Messe Frankfurt – the continent's premier pharmaceutical event connecting industry leaders across the entire supply chain. CPHI Europe brings together

Biocon Biologics in the United Kingdom, Ireland and the Nordics! Our team is dedicated to making healthcare systems more sustainable and life-improving treatments more accessible through biosimilars. We are focused on expanding access to treatments in therapeutic areas such as

We are delighted to welcome Neelkanth Chandgothia as our new Global Head – Corporate Finance, reporting to the CFO. Neel brings with him over 20 years of rich experience in finance, strategy, and leadership, and has successfully led high-value transformations across diverse

We are proud to share that Biocon Biologics has been honoured as one of the trailblazing brands at the 8th Edition of ET NOW’s Iconic Brands of India 2025!   This recognition celebrates brands that have redefined industries, set new benchmarks of excellence, and put India on the

Today, on World Sight Day, we at Biocon Biologics stand in solidarity with millions affected by serious eye conditions and celebrate our commitment to expanding access to ophthalmology treatments. Vision is precious, and every patient deserves access to therapies that can

We were honored to sponsor the Light the Night Walk hosted by Blood Cancer United, formerly the Leukemia and Lymphoma Society, this past weekend in Long Branch, NJ. This inspiring community event brought together survivors, caregivers, families and organizations to shine a light

We were proud to have our Chief Medical Officer, Uwe Gudat, participate in the Festival of Biologics in Basel from September 30th to October 2nd – Europe's largest biologics event bringing together senior professionals across the value chain.  Uwe delivered a compelling

We were proud to have our Chief Medical Officer, Uwe Gudat, participate in the Festival of Biologics in Basel from September 30th to October 2nd – Europe's largest biologics event bringing together senior professionals across the value chain.  Uwe delivered a compelling